{"fund":{"name":"Developing Growth Fund","canonicalUrls":["https://www.lordabbett.com/en-us/individual-investor/index/investments-and-performance/mutual-funds/us-equity/developing-growth-fund.html.class-a","https://www.lordabbett.com/en-us/financial-advisor/index/investments-and-performance/mutual-funds/us-equity/developing-growth-fund.html.class-a"],"assetClass":"U.S. Equity","fundType":"Mutual Fund","ticker":"LAGWX","shareClass":"A"},"banner":{"dailyPriceWoSalesCharge":27.34,"dailyPriceAsOfDate":"10/14/2026","ytdReturnsWoSalesCharge":6.67,"ytdReturnsAsOfDate":"10/14/2026","fundGrossExpenseRatio":"0.94","fundNetExpenseRatio":"0.94","expenseRatioAsOfDate":"09/30/2026"},"overview":{"summary":"The Fund’s investment objective is long-term growth of capital through a diversified and actively managed portfolio consisting of developing growth companies, many of which are traded over the counter.","approach":["Expertise - Twenty plus years of experience investing in growth portfolios for our clients","Accessing Innovation - Investing in disruptive innovators while seeking to manage risk","Differentiated Diversifier - Performance profile designed to enhance diversification and total return"],"fundFacts":{"totalNetAssets":"2054001485.17","totalNetAssetsAsOfDate":"09/30/2026","inceptionDate":"10/10/1973","minimumInitialInvestment":"1000","dividendFrequency":"Yearly","dividendFrequencyAsOfDate":"10/14/2026"},"characteristics":{"weightedAverageMarketCapitalization":"8732500000.00","earningsGrowth":"20.20%","salesGrowth":"14.40%","numberOfHoldings":"87","asOfDate":"09/30/2026"}},"investmentTeam":{"team":[{"name":"F. Thomas O'Halloran","profileURL":"https://www.lordabbett.com/content/dam/shared-assets/biography/ohalloran-thomas/ohalloran-thomas-biography.pdf","title":"Partner, Portfolio Manager","designation":"CFA, J.D.","experience":"39 years","image":{"imageURL":"https://www.lordabbett.com/content/dam/shared-assets/biography/ohalloran-thomas/ohalloran-thomas-headshot.jpg","imgAltText":"Professional Image of F. Thomas O'Halloran"}},{"name":"Matthew R. DeCicco","profileURL":"https://www.lordabbett.com/content/dam/shared-assets/biography/decicco-matthew/decicco-matthew-biography.pdf","title":"Partner, Director of Equities","designation":"CFA","experience":"27 years","image":{"imageURL":"https://www.lordabbett.com/content/dam/shared-assets/biography/decicco-matthew/decicco-matthew-headshot.jpg","imgAltText":"Professional Image of Matthew R. DeCicco"}},{"name":"Vernon Bice","profileURL":"https://www.lordabbett.com/content/dam/shared-assets/biography/bice-vernon/bice-vernon-biography.pdf","title":"Portfolio Manager","designation":"CMT","experience":"25 years","image":{"imageURL":"https://www.lordabbett.com/content/dam/shared-assets/biography/bice-vernon/bice-vernon-headshot.jpg","imgAltText":"Professional Image of Vernon Bice"}},{"name":"Benjamin Ebel","profileURL":"https://www.lordabbett.com/content/dam/shared-assets/biography/ebel-benjamin/ebel-benjamin-biography.pdf","title":"Senior Managing Director, Portfolio Manager","experience":"34 years","image":{"imageURL":"https://www.lordabbett.com/content/dam/shared-assets/biography/ebel-benjamin/ebel-benjamin-headshot.jpg","imgAltText":"Professional Image of Benjamin Ebel"}}]},"performance":{"asOfDate":"09/30/2026","returnsWithoutSalesCharge":{"ytd":14.12,"oneYear":16.03,"threeYear":21.04,"fiveYear":1.29,"tenYear":12.31,"sinceInception":10.66},"returnsWithSalesCharge":{"ytd":7.58,"oneYear":9.35,"threeYear":18.66,"fiveYear":0.1,"tenYear":11.65,"sinceInception":10.54}},"holdings":{"asOfDate":"09/30/2026","topHoldings":[{"name":"10X Genomics Inc","percentageOfAssets":3.1},{"name":"Twist Bioscience Corp","percentageOfAssets":2.69},{"name":"Guardant Health Inc","percentageOfAssets":2.64},{"name":"JFrog Ltd","percentageOfAssets":2.52},{"name":"DigitalOcean Holdings Inc","percentageOfAssets":2.34},{"name":"Adaptive Biotechnologies Corp","percentageOfAssets":2.13},{"name":"Navan Inc","percentageOfAssets":1.95},{"name":"IMAX Corp","percentageOfAssets":1.88},{"name":"WisdomTree Inc","percentageOfAssets":1.7},{"name":"Madrigal Pharmaceuticals Inc","percentageOfAssets":1.68}]},"allocation":{"asOfDate":"09/30/2026","sectorAllocation":{"communicationServices":3.4,"consumerDiscretionary":7.0,"consumerStaples":3.8,"energy":0.0,"financials":6.6,"healthCare":33.0,"industrials":13.6,"informationTechnology":29.7,"materials":0.0,"realEstate":0.0,"utilities":0.0}},"feesAndExpenses":{"asOfDate":"09/30/2026","grossExpenseRatio":0.94,"netExpenseRatio":0.94},"characteristics":{"asOfDate":"09/30/2026","weightedAverageMarketCapitalization":"8732500000.00","earningsGrowth":"20.2%","salesGrowth":"14.4%","totalNetAssets":"2054001485.17","numberOfHoldings":"87.00"}}